West Branch Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.57K Sell
30
-1
-3% -$167 ﹤0.01% 276
2026
Q1
$6.51K Hold
31
﹤0.01% 261
2025
Q4
$8.81K Hold
31
﹤0.01% 275
2025
Q3
$9.57K Hold
31
﹤0.01% 287
2025
Q2
$9.74K Hold
31
﹤0.01% 275
2025
Q1
$8.14K Hold
31
﹤0.01% 304
2024
Q4
$8.09K Hold
31
﹤0.01% 285
2024
Q3
$7.22K Buy
31
+1
+3% +$205 ﹤0.01% 304
2024
Q2
$6.05K Hold
30
﹤0.01% 318
2024
Q1
$5.14K Hold
30
﹤0.01% 332
2023
Q4
$6.51K Hold
30
﹤0.01% 312
2023
Q3
$4.79K Hold
30
﹤0.01% 345
2023
Q2
$8.65K Hold
30
﹤0.01% 295
2023
Q1
$9.57K Hold
30
0.01% 292
2022
Q4
$8.83K Hold
30
0.01% 295
2022
Q3
$7K Hold
30
﹤0.01% 316
2022
Q2
$7K Hold
30
﹤0.01% 310
2022
Q1
$8K Hold
30
﹤0.01% 318
2021
Q4
$8K Hold
30
﹤0.01% 347
2021
Q3
$9K Hold
30
﹤0.01% 322
2021
Q2
$8K Buy
+30
New +$8.15K ﹤0.01% 342

Other funds holding PODD

West Branch Capital's PODD Position: Q2 2026 in Review

West Branch Capital reduced its Insulet (PODD) stake by 3.2% in Q2 2026, selling an estimated $167 and leaving 30 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #276.

West Branch Capital first reported a position in PODD in Q2 2021 and has held it in 21 quarters since. The position peaked at $9.74K in Q2 2025. 110 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • West Branch Capital held 30 shares of Insulet worth $4.57K as of Q2 2026.
  • West Branch Capital sold 1 Insulet share in Q2 2026, an estimated $167.
  • Insulet made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #276 holding.
  • West Branch Capital first reported a position in Insulet in Q2 2021 and has held it in 21 quarters since.
  • West Branch Capital's Insulet position peaked at $9.74K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.